Cart
sales@molnova.com
Ralitoline
CAS No. 1089085-40-4
Ralitoline( —— )
Catalog No. M34390 CAS No. 1089085-40-4
Ralitoline (Ralitolinum) is an anticonvulsant with anticancer activity and sodium channel blocking activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 198 | Get Quote |
|
| 5MG | 304 | Get Quote |
|
| 10MG | 456 | Get Quote |
|
| 25MG | 723 | Get Quote |
|
| 50MG | 994 | Get Quote |
|
| 100MG | 1332 | Get Quote |
|
| 500MG | 2664 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRalitoline
-
NoteResearch use only, not for human use.
-
Brief DescriptionRalitoline (Ralitolinum) is an anticonvulsant with anticancer activity and sodium channel blocking activity.
-
DescriptionRalitoline (Ralitolinum) is an anticonvulsant with anticancer activity and sodium channel blocking activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1089085-40-4
-
Formula Weight296.77
-
Molecular FormulaC13H13ClN2O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C(NC1=C(C)C=CC=C1Cl)=O)=C2N(C)C(=O)CS2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Lidocaine hydrochlor...
Lidocaine HCl salt, an amide local anesthetic, has anti-inflammatory properties in vitro and in vivo.
-
DPI 201-106
DPI 201-106 is a cardioselective inhibitor of the TTX-resistant h1 Na channel inactivation resulting in a positive inotropic effect.
-
A-317567
A-317567 (A317567) is a novel potent acid sensing ion channel (ASIC) blocker with IC50 of 2-30 uM.
